193 related articles for article (PubMed ID: 34789240)
1. Anticancer effects of mifepristone on human uveal melanoma cells.
Alvarez PB; Laskaris A; Goyeneche AA; Chen Y; Telleria CM; Burnier JV
Cancer Cell Int; 2021 Nov; 21(1):607. PubMed ID: 34789240
[TBL] [Abstract][Full Text] [Related]
2. Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.
Tieszen CR; Goyeneche AA; Brandhagen BN; Ortbahn CT; Telleria CM
BMC Cancer; 2011 May; 11():207. PubMed ID: 21619605
[TBL] [Abstract][Full Text] [Related]
3. Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.
Sundaramurthi H; Tonelotto V; Wynne K; O'Connell F; O'Reilly E; Costa-Garcia M; Kovácsházi C; Kittel A; Marcone S; Blanco A; Pallinger E; Hambalkó S; Piulats Rodriguez JM; Ferdinandy P; O'Sullivan J; Matallanas D; Jensen LD; Giricz Z; Kennedy BN
Open Res Eur; 2023; 3():88. PubMed ID: 37981907
[TBL] [Abstract][Full Text] [Related]
4. Modulation of AMPK Significantly Alters Uveal Melanoma Tumor Cell Viability.
Deliktas O; Gedik ME; Koc I; Gunaydin G; Kiratli H
Ophthalmic Res; 2023; 66(1):1230-1244. PubMed ID: 37647867
[TBL] [Abstract][Full Text] [Related]
5. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro.
Fiorentzis M; Kalirai H; Katopodis P; Seitz B; Viestenz A; Coupland SE
Neoplasma; 2018; 65(2):210-215. PubMed ID: 29534581
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA polymorphisms and biogenesis genes in primary and metastatic uveal melanoma cell lines.
Singh L; Atilano SR; Jager MJ; Kenney MC
Cancer Genet; 2021 Aug; 256-257():91-99. PubMed ID: 34082186
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.
Calipel A; Landreville S; De La Fouchardière A; Mascarelli F; Rivoire M; Penel N; Mouriaux F
Clin Exp Metastasis; 2014 Jun; 31(5):553-64. PubMed ID: 24652072
[TBL] [Abstract][Full Text] [Related]
8. Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior.
Pawlik VE; Sonntag SR; Grisanti S; Tura A; Kakkassery V; Ranjbar M
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):30. PubMed ID: 38381412
[TBL] [Abstract][Full Text] [Related]
9. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
10. Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.
Rose FV; Barnea ER
Oncogene; 1996 Mar; 12(5):999-1003. PubMed ID: 8649817
[TBL] [Abstract][Full Text] [Related]
11. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
12. Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and Metastasis.
Draper J; Alexander J; Nair RM; Scullion N; Narayana RVL; Aughton K; Herrmann A; Vemuganti GK; Kalirai H; Coupland SE
Curr Eye Res; 2023 Apr; 48(4):408-415. PubMed ID: 36484268
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
[TBL] [Abstract][Full Text] [Related]
14. Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.
Shu W; Wang JZ; Zhu X; Wang K; Cherepanoff S; Conway RM; Madigan MC; Lim LA; Zhu H; Zhu L; Murray M; Zhou F
J Cancer; 2023; 14(18):3477-3495. PubMed ID: 38021158
[TBL] [Abstract][Full Text] [Related]
15. High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.
Moe BG; Vereide AB; Orbo A; Sager G
Anticancer Res; 2009 Apr; 29(4):1053-8. PubMed ID: 19414345
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.
Cools-Lartigue JJ; McCauley CS; Marshall JC; Di Cesare S; Gregoire F; Antecka E; Logan P; Burnier MN
Mol Vis; 2008 Jan; 14():50-5. PubMed ID: 18246031
[TBL] [Abstract][Full Text] [Related]
17. Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor.
Sundaramurthi H; García-Mulero S; Tonelotto V; Slater K; Marcone S; Piulats JM; Watson RW; Tobin DJ; Jensen LD; Kennedy BN
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159049
[TBL] [Abstract][Full Text] [Related]
18. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
19. Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Oláh G; Dobos N; Vámosi G; Szabó Z; Sipos É; Fodor K; Harda K; Schally AV; Halmos G
Eur J Pharm Sci; 2018 Oct; 123():371-376. PubMed ID: 30076951
[TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy.
Kalirai H; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8458-66. PubMed ID: 21896849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
